{"id":409290,"date":"2021-01-06T07:20:43","date_gmt":"2021-01-06T12:20:43","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=409290"},"modified":"2021-01-06T07:20:43","modified_gmt":"2021-01-06T12:20:43","slug":"appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\/","title":{"rendered":"Appili Therapeutics to Present at the 2021 VIRTUAL H.C. Wainwright BioConnect Conference"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Appili Therapeutics to Present at the 2021 VIRTUAL H.C. Wainwright BioConnect Conference<\/b><\/p>\n<p>HALIFAX, Nova Scotia&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nAppili Therapeutics Inc. (TSX: APLI, OTCQX: APLIF) (the \u201cCompany\u201d or \u201cAppili\u201d), a biopharmaceutical company focused on anti-infective drug development, announced today that <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.appilitherapeutics.com%2Fleadership&amp;esheet=52357036&amp;newsitemid=20210106005145&amp;lan=en-US&amp;anchor=Appili%26%238217%3Bs+CEO+Dr.+Armand+Balboni&amp;index=1&amp;md5=bd1971bbe9dab72123f5b41fd8fcec1c\">Appili\u2019s CEO Dr. Armand Balboni<\/a> will participate in HC Wainwright\u2019s Bioconnect 2021 investor event. The virtual conference takes place from January 11 \u2013 14, 2021.\n<\/p>\n<p><b>Presentation details are as follows:<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nType: Pre-recorded Company Presentation from Dr. Balboni\n<\/li>\n<li>\nDate: Monday January 11, 2021 <i>(on demand for one week) <\/i><\/li>\n<li>\nTime: Starting at 6:00 AM ET\n<\/li>\n<\/ul>\n<p><b>About the Conference<br \/>\n<br \/><\/b>This is the inaugural virtual H.C. Wainwright BioConnect Conference. H.C. Wainwright is hosting the event to provide clients with a forum to virtually present to investors during the timeframe of the JP Morgan Healthcare Conference. This event will include Company Presentations, Fireside Chats, Investment Banking Meetings, and Research Meetings.\n<\/p>\n<p><b>About Appili Therapeutics<br \/>\n<br \/><\/b>Appili Therapeutics is an infectious disease biopharmaceutical company that is purposefully built, portfolio-driven and people-focused to fulfill its mission of solving life-threatening infections. By systematically identifying urgent infections with unmet needs, Appili\u2019s goal is to strategically develop a pipeline of novel therapies to prevent deaths and improve lives. As part of a global consortium, Appili is sponsoring late-stage clinical trials evaluating the antiviral Avigan\u00ae (favipiravir) for the worldwide treatment and prevention of COVID-19. The Company is also advancing a diverse range of anti-infectives, including a broad-spectrum antifungal, a vaccine candidate to eliminate a serious biological weapon threat, and two novel antibiotic programs. Led by a proven management team, Appili is at the epicenter of the global fight against infection. For more information, connect at AppiliTherapeutics.com.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210106005145r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210106005145\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210106005145\/en\/<\/a><\/span><\/p>\n<p>\nInvestor Relations Contact:<br \/>\n<br \/>Kimberly Stephens, CFO<br \/>\n<br \/>Appili Therapeutics<br \/>\n<br \/>E: <a rel=\"nofollow\" href=\"mailto:Info@AppiliTherapeutics.com\">Info@AppiliTherapeutics.com<\/a><\/p>\n<p>\nMedia Relations Contact:<br \/>\n<br \/>Andrea Cohen, Sam Brown Inc.<br \/>\n<br \/>T: 917-209-7163<br \/>\n<br \/>E: <a rel=\"nofollow\" href=\"mailto:andreacohen@sambrown.com\">andreacohen@sambrown.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> North America Canada<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Infectious Diseases Health Pharmaceutical Clinical Trials<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210106005145\/en\/850389\/3\/AppiliLogo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Appili Therapeutics to Present at the 2021 VIRTUAL H.C. Wainwright BioConnect Conference HALIFAX, Nova Scotia&#8211;(BUSINESS WIRE)&#8211; Appili Therapeutics Inc. (TSX: APLI, OTCQX: APLIF) (the \u201cCompany\u201d or \u201cAppili\u201d), a biopharmaceutical company focused on anti-infective drug development, announced today that Appili\u2019s CEO Dr. Armand Balboni will participate in HC Wainwright\u2019s Bioconnect 2021 investor event. The virtual conference takes place from January 11 \u2013 14, 2021. Presentation details are as follows: Type: Pre-recorded Company Presentation from Dr. Balboni Date: Monday January 11, 2021 (on demand for one week) Time: Starting at 6:00 AM ET About the Conference This is the inaugural virtual H.C. Wainwright BioConnect Conference. H.C. Wainwright is hosting the event to provide clients with a forum to virtually present to investors &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Appili Therapeutics to Present at the 2021 VIRTUAL H.C. Wainwright BioConnect Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-409290","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Appili Therapeutics to Present at the 2021 VIRTUAL H.C. Wainwright BioConnect Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Appili Therapeutics to Present at the 2021 VIRTUAL H.C. Wainwright BioConnect Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Appili Therapeutics to Present at the 2021 VIRTUAL H.C. Wainwright BioConnect Conference HALIFAX, Nova Scotia&#8211;(BUSINESS WIRE)&#8211; Appili Therapeutics Inc. (TSX: APLI, OTCQX: APLIF) (the \u201cCompany\u201d or \u201cAppili\u201d), a biopharmaceutical company focused on anti-infective drug development, announced today that Appili\u2019s CEO Dr. Armand Balboni will participate in HC Wainwright\u2019s Bioconnect 2021 investor event. The virtual conference takes place from January 11 \u2013 14, 2021. Presentation details are as follows: Type: Pre-recorded Company Presentation from Dr. Balboni Date: Monday January 11, 2021 (on demand for one week) Time: Starting at 6:00 AM ET About the Conference This is the inaugural virtual H.C. Wainwright BioConnect Conference. H.C. Wainwright is hosting the event to provide clients with a forum to virtually present to investors &hellip; Continue reading &quot;Appili Therapeutics to Present at the 2021 VIRTUAL H.C. Wainwright BioConnect Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-06T12:20:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210106005145r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Appili Therapeutics to Present at the 2021 VIRTUAL H.C. Wainwright BioConnect Conference\",\"datePublished\":\"2021-01-06T12:20:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\\\/\"},\"wordCount\":338,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210106005145r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\\\/\",\"name\":\"Appili Therapeutics to Present at the 2021 VIRTUAL H.C. Wainwright BioConnect Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210106005145r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-01-06T12:20:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210106005145r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210106005145r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Appili Therapeutics to Present at the 2021 VIRTUAL H.C. Wainwright BioConnect Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Appili Therapeutics to Present at the 2021 VIRTUAL H.C. Wainwright BioConnect Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\/","og_locale":"en_US","og_type":"article","og_title":"Appili Therapeutics to Present at the 2021 VIRTUAL H.C. Wainwright BioConnect Conference - Market Newsdesk","og_description":"Appili Therapeutics to Present at the 2021 VIRTUAL H.C. Wainwright BioConnect Conference HALIFAX, Nova Scotia&#8211;(BUSINESS WIRE)&#8211; Appili Therapeutics Inc. (TSX: APLI, OTCQX: APLIF) (the \u201cCompany\u201d or \u201cAppili\u201d), a biopharmaceutical company focused on anti-infective drug development, announced today that Appili\u2019s CEO Dr. Armand Balboni will participate in HC Wainwright\u2019s Bioconnect 2021 investor event. The virtual conference takes place from January 11 \u2013 14, 2021. Presentation details are as follows: Type: Pre-recorded Company Presentation from Dr. Balboni Date: Monday January 11, 2021 (on demand for one week) Time: Starting at 6:00 AM ET About the Conference This is the inaugural virtual H.C. Wainwright BioConnect Conference. H.C. Wainwright is hosting the event to provide clients with a forum to virtually present to investors &hellip; Continue reading \"Appili Therapeutics to Present at the 2021 VIRTUAL H.C. Wainwright BioConnect Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-06T12:20:43+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210106005145r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Appili Therapeutics to Present at the 2021 VIRTUAL H.C. Wainwright BioConnect Conference","datePublished":"2021-01-06T12:20:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\/"},"wordCount":338,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210106005145r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\/","name":"Appili Therapeutics to Present at the 2021 VIRTUAL H.C. Wainwright BioConnect Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210106005145r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-01-06T12:20:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210106005145r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210106005145r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/appili-therapeutics-to-present-at-the-2021-virtual-h-c-wainwright-bioconnect-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Appili Therapeutics to Present at the 2021 VIRTUAL H.C. Wainwright BioConnect Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/409290","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=409290"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/409290\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=409290"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=409290"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=409290"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}